Phuong Vo
Fred Hutch/University of Washington Cancer Consortium · Fred Hutchinson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Phuong Vo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07819396 · Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeFred Hutchinson Cancer Center · not yet recruiting · Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage · principal investigator
- Ph2NCT04994808 · Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid LeukemiaFred Hutchinson Cancer Center · terminated · Acute Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph1NCT04579523 · ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple MyelomaFred Hutchinson Cancer Center · withdrawn · Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma · principal investigator
- Ph2NCT04195633 · Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesFred Hutchinson Cancer Center · recruiting · Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia · principal investigator
- Ph1/Ph2NCT04083183 · Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant DiseasesFred Hutchinson Cancer Center · recruiting · Non-Malignant Neoplasm · principal investigator
- Ph1/Ph2NCT03670966 · 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeFred Hutchinson Cancer Center · recruiting · Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 3: Integrating Plasma Cell-Specific Radioimmunotherapy into Allogeneic Stem Cell Transplantation for MyelomaP01CA078902 · NCI · FRED HUTCHINSON CANCER CENTER · PI Damian J. Green · fiscal years 2018 to 2025Named on NCT04579523, NCT03670966
- Core B: Biostatistics and Data ManagementP01HL122173 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Barry E. Storer · fiscal years 2018 to 2019Named on NCT04083183
- Cancer Center AdministrationP30CA015704 · NCI · FRED HUTCHINSON CANCER CENTER · PI WENDY LAW · fiscal years 2018 to 2026Named on NCT03670966
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.